Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Agitation and Aeration Monitoring in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Agitation and Aeration Monitoring in Bioreactor Operations – V 2.0


Standard Operating Procedure for Agitation and Aeration Monitoring in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/071/2025
Supersedes SOP/BS/071/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the procedure for monitoring and adjusting agitation and aeration parameters in bioreactor systems to ensure proper mixing, oxygen transfer, and cell viability during biosimilar production.

2. Scope

This SOP applies to all stirred-tank bioreactors (10L–2000L) used in upstream biosimilar processes involving mammalian cell culture systems such as CHO and HEK293 lines.

3. Responsibilities

  • Process Operators: Monitor agitation RPM and gas flow rates, respond to alarms, and record data.
  • Engineering: Maintain sparger, gas lines, and agitation motors.
  • QA: Review logs and confirm adherence to specified process parameters.

4. Accountability

The Upstream Process Head is accountable for ensuring bioreactor agitation and aeration systems operate within validated parameters and deviations are appropriately handled.

5. Procedure

5.1 Pre-Run Checks

  1. Ensure agitation system is functional and calibrated (Annexure-1).
  2. Inspect sparger and verify gas filters and valves are intact.
  3. Set initial agitation speed (e.g., 80–120 RPM) as per batch record.
  4. Configure aeration rate (typically 0.05–0.1 vvm) and oxygen blending setup.

5.2 Real-Time Monitoring

  1. Record agitation speed and gas flow rate every 2 hours using the control system interface.
  2. Monitor cascade control: agitation should respond to DO drops by ramping up gradually.
  3. Check for foaming or vortex formation—adjust RPM if necessary.
  4. Document readings in Annexure-2.

5.3 Adjustments During Culture

  1. Increase agitation speed if DO or pH drifts despite gas adjustments.
  2. Check for gas leaks or blockages if aeration is ineffective.
  3. In case of foaming, refer to SOP/BS/072/2025 for antifoam addition.

5.4 Post-Run Handling

  1. Shut down agitator and gas supply after harvesting.
  2. Document shutdown parameters in Annexure-3.
  3. Schedule cleaning and maintenance of sparger and impeller.

6. Abbreviations

  • RPM: Revolutions Per Minute
  • vvm: Volume of gas per volume of liquid per minute
  • DO: Dissolved Oxygen

7. Documents

  1. Agitation & Aeration System Checklist – Annexure-1
  2. Agitation & Aeration Monitoring Log – Annexure-2
  3. Shutdown Summary Report – Annexure-3

8. References

  • WHO TRS 1010 – GMP for Biological Products
  • ICH Q8 – Pharmaceutical Development
  • SOP/BS/072/2025 – Antifoam Handling

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Agitation & Aeration System Checklist

Parameter Status Checked By Date
Motor Functionality OK Rajesh Kumar 04/05/2025
Sparger Flow OK Rajesh Kumar 04/05/2025

Annexure-2: Agitation & Aeration Monitoring Log

Date Time RPM Gas Flow (vvm) Remarks
04/05/2025 10:00 100 0.08 Normal

Annexure-3: Shutdown Summary Report

Batch ID Final RPM Final Gas Flow Shutdown Time Operator
BR-113 80 0.00 19:15 Ajay Verma

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added sparger inspection and Annexure-3 Process Optimization
See also  Biosimilars: SOP for Creation of Working Cell Bank (WCB) - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Elixir Department: SOP for Use of Jacketed Vessels – V 2.0
Next Post: BA-BE Studies: SOP for Clinical Trial Material Storage at Site – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version